Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global Covid-19 Vaccine Acceptance Rate: A Systematic Review and Meta-Analysis Publisher



Alimohamadi Y1 ; Hosamirudsari H2 ; Hesari E3 ; Sepandi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  2. 2. Department of Infectious Diseases, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics School of public health, Tehran University of Medical Science, Tehran, Iran

Source: Journal of Public Health (Germany) Published:2023


Abstract

Aim: Achieving high COVID-19 vaccination coverage rates is essential as soon as a vaccine is available to deal with and end this pandemic. Due to the different amounts of COVID-19 vaccine acceptance rates in different regions, the pooled estimation of this rate is essential. Therefore, we conducted a systematic review and meta-analysis to investigate worldwide COVID-19 vaccine acceptance rates. Subject and methods: International databases (including, Web of sciences, PubMed, and Scopus) were searched to identify related studies. The heterogeneity among studies was assessed using the I2 index, the Cochran Q test, and T2. A random-effects model was used to pool estimate vaccine acceptance rates. Results: The overall pooled estimate of COVID-19 vaccine acceptance rate was 65.1 (95% CI 60.1–70.1; P < 0.001, I2 = 99.8). The vaccine acceptance rate in the general population was 68.5 (95% CI 62.5–74.5; P < 0.001, I2 = 99.8) and among healthcare workers (HCWs) was 55.9 (95% CI 47.8–64.1; P < 0.001, I2 = 99.6). The lowest COVID-19 vaccine acceptance rate was in the Middle East (46.1% (35.1–57.0)), and the highest coverage rate was (85% (71–99.1)) in South America. Conclusion: COVID-19 vaccine acceptance rate among HCWs is lower than the general population. More studies are recommended to identify related factors to the COVID-19 vaccine acceptance rate. © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Related Docs
View other Related Docs
1. Public Acceptability of Covid-19 Vaccines and Its Predictors in Middle ‎Eastern/North African (Mena) Countries: A Systematic Review‎, Human Vaccines and Immunotherapeutics (2022)
2. The Predictive Role of Parental Attitudes Toward Covid-19 Vaccines and Child Vulnerability: A Multi-Country Study on the Relationship Between Parental Vaccine Hesitancy and Financial Well-Being, Frontiers in Public Health (2023)
3. Acceptance or Rejection of the Covid-19 Vaccine: A Study on Iranian People’S Opinions Toward the Covid-19 Vaccine, Vaccines (2022)
4. Severity of Sars-Cov-2 Reinfection in Vaccinated Healthcare Workers, Iranian Journal of Microbiology (2023)
5. “Intention to Receive Covid-19 Vaccine Among Healthcare Workers: A Comparison Between Two Surveys”, BMC Health Services Research (2022)
6. Perspectives of Medical Sciences Students Regarding Covid-19 Vaccination: A Cross-Sectional Study, BMC Health Services Research (2025)
7. Covid-19 Vaccination in Children As a Global Dilemma Through an Ethical Lens: A Retrospective Review, Health Science Reports (2023)
8. Covid-19 Vaccine Hesitancy in Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (3)
Amirreza Azimi (1)
Other Related Docs
9. Physicians’ Opinions on the Necessity of Covid-19 Vaccination in Patients With Epilepsy, Epileptic Disorders (2021)
10. Exploring the Factors Influencing the Adult Population’S Reluctance to Accept the Covid-19 Vaccine in Tehran, BMC Health Services Research (2024)
11. A Multinational Delphi Consensus to End the Covid-19 Public Health Threat, Nature (2022)
12. Assessment of Covid-19 Vaccine Attitude in People With Multiple Sclerosis, Its Correlation With Demographic Factors, and Fear of Coronavirus: A Cross-Sectional Survey, Current Journal of Neurology (2022)